Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
RealTimeImage Inc. has been granted U.S. Food and Drug Administration 510k approval to market its iPACS OrthoPlanner for the orthopedic market in the United States.
U.S. Electronics Inc. (USEI) this week received U.S. Food and Drug Administration 510k clearance for use of a flat-panel display for the diagnostic reading of mammography images in PACS (picture archiving and communications systems) applications.
Planar Systems Inc. this week received U.S. Food & Drug Administration 510k approval to market its flat-panel Dome C5i system for displaying and viewing mammograms.
Varian Medical Systems Inc. will deploy its Eclipse radiotherapy treatment planning system at the Vanderbilt-Ingram Cancer Center of Nashville, Tenn. - marking the Eclipse's 2000th installation.
Computer Consultants & Merchants Inc. (CC&M) and Zvetco Biometrics of Orlando. Fla., have deployed an integrated biometric security system at West Tennessee Healthcare.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
